Anebulo Pharmaceuticals, Inc. — All Filings
198 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
15-12G
25
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13D
SC 13E3
SC 13E3/A
SC TO-I
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 15-12G | 15-12G | 0001493152-26-008559 | Mar 2, 2026 | — |
| 25 | 25 | 0001493152-26-007168 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015319 | Feb 13, 2026 | — |
| 10-Q | 10-Q | 0001493152-26-006446 | Feb 12, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001493152-26-006428 | Feb 12, 2026 | — |
| 8-K | 8-K | 0001493152-26-005463 | Feb 6, 2026 | Feb 5, 2026 |
| SC 13E3/A | SC TO-I/A | 0001493152-26-004156 | Jan 29, 2026 | — |
| 8-K | 8-K | 0001493152-26-004154 | Jan 29, 2026 | — |
| SC 13E3/A | SC TO-I/A | 0001493152-26-003720 | Jan 27, 2026 | — |
| 8-K | 8-K | 0001493152-26-003718 | Jan 27, 2026 | Jan 26, 2026 |
| SC 13E3/A | SC TO-I/A | 0001493152-26-000914 | Jan 8, 2026 | — |
| SC 13E3 | SC TO-I | 0001493152-25-028828 | Dec 22, 2025 | — |
| SC TO-I | SC TO-I | 0001493152-25-028680 | Dec 22, 2025 | — |
| 8-K | 8-K | 0001493152-25-028676 | Dec 22, 2025 | — |
| 10-Q | 10-Q | 0001493152-25-022350 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001493152-25-022310 | Nov 13, 2025 | — |
| SC 13E3/A | SC 13E3/A | 0001493152-25-017826 | Oct 14, 2025 | — |
| PRER14A | PRER14A | 0001493152-25-017820 | Oct 10, 2025 | — |
| 10-K | 10-K | 0001493152-25-016015 | Sep 29, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001493152-25-016001 | Sep 29, 2025 | — |
| S-8 POS | S-8 POS | 0001493152-25-015078 | Sep 26, 2025 | — |
| S-8 POS | S-8 POS | 0001493152-25-015075 | Sep 26, 2025 | — |
| EFFECT | — | 9999999995-25-003064 | Sep 23, 2025 | — |
| EFFECT | — | 9999999995-25-003060 | Sep 23, 2025 | — |
| POS AM | POS AM | 0001493152-25-014238 | Sep 19, 2025 | — |
| POS AM | POS AM | 0001493152-25-014228 | Sep 19, 2025 | — |
| SC 13E3/A | SC 13E3/A | 0001493152-25-013386 | Sep 15, 2025 | — |
| PRER14A | PRER14A | 0001493152-25-013373 | Sep 15, 2025 | — |
| 8-K | 8-K | 0001493152-25-013133 | Sep 12, 2025 | — |
| 8-K | 8-K | 0001493152-25-011342 | Jul 23, 2025 | — |
| SC 13E3 | SC 13E3 | 0001493152-25-011341 | Jul 23, 2025 | — |
| PRE 14A | PRE 14A | 0001493152-25-011339 | Jul 23, 2025 | — |
| S-8 | S-8 | 0001641172-25-010854 | May 15, 2025 | — |
| 10-Q | FORM 10-Q | 0001641172-25-009975 | May 13, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001641172-25-009952 | May 13, 2025 | — |
| 8-K | — | 0001641172-25-004799 | Apr 15, 2025 | Apr 11, 2025 |
| 8-K | — | 0001641172-25-003913 | Apr 14, 2025 | Apr 11, 2025 |
| 4 | — | 0001641172-25-003093 | Apr 7, 2025 | Apr 4, 2025 |
| 4 | — | 0001641172-25-003089 | Apr 7, 2025 | Apr 4, 2025 |
| 4 | — | 0001641172-25-003090 | Apr 7, 2025 | Apr 4, 2025 |
| 4 | — | 0001641172-25-003092 | Apr 7, 2025 | Apr 4, 2025 |
| 4 | — | 0001641172-25-003095 | Apr 7, 2025 | Apr 4, 2025 |
| 4 | — | 0001641172-25-003091 | Apr 7, 2025 | Apr 4, 2025 |
| 4 | — | 0001641172-25-003088 | Apr 7, 2025 | Apr 4, 2025 |
| 4 | — | 0001641172-25-003094 | Apr 7, 2025 | Apr 4, 2025 |
| 4 | — | 0001641172-25-003087 | Apr 7, 2025 | Apr 4, 2025 |
| 8-K | — | 0001641172-25-002862 | Apr 7, 2025 | Apr 4, 2025 |
| SCHEDULE 13G | — | 0001172661-25-001355 | Mar 17, 2025 | — |
| ARS | — | 0001493152-25-009318 | Mar 6, 2025 | Jun 30, 2024 |
| DEF 14A | — | 0001493152-25-009311 | Mar 6, 2025 | — |